Lessons from the contrast dye shortage during COVID-19: A narrative review.
Christiaan YuPublished in: Medicine (2023)
The sudden contrast dye shortage, precipitated by a temporary forced closure of healthcare plant, has limited the supply of iodinated contrast media to Australia. Furthering the impact of the coronavirus disease 2019 pandemic, this new crisis has increased burden on the radiology system. Lessons from the strategies applied during the shortage should be used as building blocks as safeguards for the future. A pragmatic approach to education and training is required in an ever-changing environment. Our relationships between medical specialties and manufacturers are paramount to maintaining an effective workflow. An ongoing commitment to a strong workforce will be the backbone to overcome another challenge in these uncertain times.
Keyphrases
- coronavirus disease
- healthcare
- magnetic resonance
- public health
- contrast enhanced
- sars cov
- highly efficient
- artificial intelligence
- clinical trial
- respiratory syndrome coronavirus
- randomized controlled trial
- current status
- magnetic resonance imaging
- risk factors
- electronic health record
- machine learning
- health information